Therma Bright (TSE:THRM) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Therma Bright Inc. celebrates the successful initial clinical trial results of the PREVA™ ischemic stroke device, developed by its investment partner Inretio, which were presented at the BRAIN Conference 2024. The device promises to revolutionize stroke care by improving patient recovery outcomes, marking a significant milestone for Inretio’s clinical program.
For further insights into TSE:THRM stock, check out TipRanks’ Stock Analysis page.
